Literature DB >> 30393605

Lung cancer and chronic obstructive pulmonary disease: understanding the complexity of carcinogenesis.

Cecilia Mouronte-Roibás1, Alberto Ruano-Raviña2,3, Alberto Fernández-Villar1.   

Abstract

Entities:  

Year:  2018        PMID： 30393605      PMCID： PMC6193892          DOI： 10.21037/tlcr.2018.08.11

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  20 in total

1.  Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD.

Authors:  Esther Barreiro; Clara Fermoselle; Mercè Mateu-Jimenez; Albert Sánchez-Font; Lara Pijuan; Joaquim Gea; Víctor Curull
Journal:  Free Radic Biol Med       Date:  2013-08-13       Impact factor: 7.376

2.  Multi-omic molecular profiling of lung cancer in COPD.

Authors:  Brian J Sandri; Adam Kaplan; Shane W Hodgson; Mark Peterson; Svetlana Avdulov; LeeAnn Higgins; Todd Markowski; Ping Yang; Andrew H Limper; Timothy J Griffin; Peter Bitterman; Eric F Lock; Chris H Wendt
Journal:  Eur Respir J       Date:  2018-07-04       Impact factor: 16.671

3.  Lung cancer histologies associated with emphysema on computed tomography.

Authors:  Benjamin M Smith; Kevin Schwartzman; Bojan Kovacina; Jana Taylor; Goulnar Kasymjanova; Guilherme Brandao; Jason S Agulnik
Journal:  Lung Cancer       Date:  2011-09-25       Impact factor: 5.705

4.  Translation initiation factor eIF-4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma.

Authors:  C Bauer; I Diesinger; N Brass; H Steinhart; H Iro; E U Meese
Journal:  Cancer       Date:  2001-08-15       Impact factor: 6.860

5.  Changes in clinical presentation and staging of lung cancer over two decades.

Authors:  Virginia Leiro-Fernández; Cecilia Mouronte-Roibás; Cristina Ramos-Hernández; Maribel Botana-Rial; Ana González-Piñeiro; Esmeralda García-Rodríguez; Cristina Represas-Represas; Alberto Fernández-Villar
Journal:  Arch Bronconeumol       Date:  2014-05-09       Impact factor: 4.872

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  A preliminary transcriptome map of non-small cell lung cancer.

Authors:  Takeshi Fujii; Tatiana Dracheva; Audrey Player; Susan Chacko; Robert Clifford; Robert L Strausberg; Kenneth Buetow; Norio Azumi; William D Travis; Jin Jen
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

8.  COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.

Authors:  R P Young; R J Hopkins; T Christmas; P N Black; P Metcalf; G D Gamble
Journal:  Eur Respir J       Date:  2009-02-05       Impact factor: 16.671

9.  Identification of proteomic signatures associated with lung cancer and COPD.

Authors:  M D Pastor; A Nogal; S Molina-Pinelo; R Meléndez; A Salinas; M González De la Peña; J Martín-Juan; J Corral; R García-Carbonero; A Carnero; L Paz-Ares
Journal:  J Proteomics       Date:  2013-05-09       Impact factor: 4.044

Review 10.  The relationship between COPD and lung cancer.

Authors:  A L Durham; I M Adcock
Journal:  Lung Cancer       Date:  2015-08-29       Impact factor: 5.705
View more
  3 in total

1.  Multiple microarray analyses identify key genes associated with the development of Non-Small Cell Lung Cancer from Chronic Obstructive Pulmonary Disease.

Authors:  Lemeng Zhang; Jianhua Chen; Hua Yang; Changqie Pan; Haitao Li; Yongzhong Luo; Tianli Cheng
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

2.  Transcriptomic data exploration of consensus genes and molecular mechanisms between chronic obstructive pulmonary disease and lung adenocarcinoma.

Authors:  Siyu Zhang; Kun Pang; Xinyu Feng; Yulan Zeng
Journal:  Sci Rep       Date:  2022-08-02       Impact factor: 4.996

3.  The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer.

Authors:  Aiping Ma; Guangdong Wang; Yan Du; Weixi Guo; Jiaxi Guo; Yi Hu; Dongyu Bai; Huiping Huang; Lianjin Zhuang; Jinhan Chen; Qun Liu
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.